Inventor
HSIA JEN-CHANG
US21 patents
⚠️ This page may combine multiple inventors who share the name “HSIA JEN-CHANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
(unassigned)
10 patentsUS5840701ANov 24, 1998
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
54 citations96
US5789376AAug 4, 1998
Transfusions with stabilized hemoglobin covalently bound to a nitroxide or polymers thereof
37 citations96
US5725839AMar 10, 1998
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
52 citations96
US5824781AOct 20, 1998
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
34 citations92
US5817632AOct 6, 1998
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
41 citations92
US5811005ASep 22, 1998
Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix
19 citations92
US5807831ASep 15, 1998
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
25 citations92
US5804561ASep 8, 1998
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
33 citations92
US5767089AJun 16, 1998
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
26 citations92
US5741893AApr 21, 1998
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
46 citations92
SYNZYME TECHNOLOGIES INC
3 patentsUS6458758B1Oct 1, 2002
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
SYNZYME TECHNOLOGIES INC34 citations92
US6323175B1Nov 27, 2001
Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
SYNZYME TECHNOLOGIES INC15 citations92
US6048967AApr 11, 2000
Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
SYNZYME TECHNOLOGIES INC14 citations81